📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. (2016)

First Author: Cooles FA

Attributed to: Study into the potentially therapeutic immunomodulatory effects of gp120 in autoimmune rheumatic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13075-016-1188-6

PubMed Identifier: 27993172

Publication URI: http://europepmc.org/abstract/MED/27993172

Type: Journal Article/Review

Volume: 18

Parent Publication: Arthritis research & therapy

Issue: 1

ISSN: 1478-6354